Cui Cui
Stock Analyst at Jefferies
(4.30)
# 1,322
Out of 4,501 analysts
32
Total ratings
60%
Success rate
28.6%
Average return
Main Sectors:
Stocks Rated by Cui Cui
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 0241 Alibaba Health Information Technology Limited | Maintained: Buy | $8.00 → $5.30 | $3.47 | +52.74% | 2 | May 19, 2026 | |
| HKG: 1548 Genscript Biotech Corporation | Maintained: Buy | $15.50 | $13.84 | +11.99% | 1 | Apr 3, 2026 | |
| HKG: 9966 Alphamab Oncology | Maintained: Buy | $9.60 | $7.66 | +25.33% | 1 | Mar 27, 2026 | |
| HKG: 1833 Ping An Healthcare and Technology Company Limited | Maintained: Hold | $12.40 | $7.54 | +64.46% | 1 | Mar 25, 2026 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $226.00 | $97.25 | +132.39% | 3 | Oct 19, 2025 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Maintained: Buy | $500.00 | $223.40 | +123.81% | 2 | Oct 8, 2025 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Maintained: Buy | $300.00 → $520.00 | $516.50 | +0.68% | 3 | Aug 19, 2025 | |
| HKG: 6618 JD Health International Inc. | Maintained: Buy | $60.00 → $88.00 | $37.30 | +135.92% | 3 | Aug 15, 2025 | |
| HKG: 1093 CSPC Pharmaceutical Group Limited | Maintained: Sell | $5.00 | $8.11 | -38.35% | 1 | Jul 30, 2025 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Maintained: Buy | $45.00 | $37.96 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41.00 → $60.00 | $60.30 | n/a | 2 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $175.00 → $87.40 | $155.10 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40.00 | $89.70 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.00 | $2.12 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10.80 | $7.92 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26.00 | $16.73 | n/a | 1 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110.00 | $36.66 | n/a | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40.00 → $35.20 | $25.70 | n/a | 2 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28.00 → $25.00 | $31.94 | n/a | 2 | Sep 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10.00 | $18.07 | n/a | 1 | Apr 22, 2020 |
Alibaba Health Information Technology Limited
May 19, 2026
Maintained: Buy
Price Target: $8.00 → $5.30
Current: $3.47
Upside: +52.74%
Genscript Biotech Corporation
Apr 3, 2026
Maintained: Buy
Price Target: $15.50
Current: $13.84
Upside: +11.99%
Alphamab Oncology
Mar 27, 2026
Maintained: Buy
Price Target: $9.60
Current: $7.66
Upside: +25.33%
Ping An Healthcare and Technology Company Limited
Mar 25, 2026
Maintained: Hold
Price Target: $12.40
Current: $7.54
Upside: +64.46%
Akeso, Inc.
Oct 19, 2025
Maintained: Buy
Price Target: $226.00
Current: $97.25
Upside: +132.39%
Duality Biotherapeutics, Inc.
Oct 8, 2025
Maintained: Buy
Price Target: $500.00
Current: $223.40
Upside: +123.81%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Aug 19, 2025
Maintained: Buy
Price Target: $300.00 → $520.00
Current: $516.50
Upside: +0.68%
JD Health International Inc.
Aug 15, 2025
Maintained: Buy
Price Target: $60.00 → $88.00
Current: $37.30
Upside: +135.92%
CSPC Pharmaceutical Group Limited
Jul 30, 2025
Maintained: Sell
Price Target: $5.00
Current: $8.11
Upside: -38.35%
WuXi Biologics (Cayman) Inc.
Mar 31, 2025
Maintained: Buy
Price Target: $45.00
Current: $37.96
Upside: n/a
Mar 27, 2025
Maintained: Buy
Price Target: $41.00 → $60.00
Current: $60.30
Upside: n/a
Mar 21, 2025
Maintained: Buy
Price Target: $175.00 → $87.40
Current: $155.10
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: $40.00
Current: $89.70
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: $4.00
Current: $2.12
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: $10.80
Current: $7.92
Upside: n/a
Nov 3, 2023
Maintained: Buy
Price Target: $26.00
Current: $16.73
Upside: n/a
Oct 31, 2023
Maintained: Buy
Price Target: $110.00
Current: $36.66
Upside: n/a
Oct 27, 2023
Maintained: Buy
Price Target: $40.00 → $35.20
Current: $25.70
Upside: n/a
Sep 4, 2023
Maintained: Buy
Price Target: $28.00 → $25.00
Current: $31.94
Upside: n/a
Apr 22, 2020
Downgraded: Hold
Price Target: $10.00
Current: $18.07
Upside: n/a